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Monoclonal antibodies (mAbs) are successful biother-
apeutics in the treatment of various diseases [1]. During
manufacturing of mAbs higher molecular weight
(HMW) aggregates can be formed during upstream
(USP) and downstream (DSP) processing, which nega-
tively influence product yields, reduce the therapeutic
efficacy of the mAbs and trigger immunogenic responses
upon administration [2,3]. Reducing the level of aggre-
gates during USP could improve the production of bio-
pharmaceuticals and reduce the burden on expensive
DSP removal of the HMW species [4]. However, the
lack of analytical tools to detect mAb aggregates in USP
restricts understanding the origin of the aggregates and
identifying cell culture conditions influencing product
quality to reduce the level of mAb aggregates [5]. We
present a high-throughput compatible method which
allows quantification of mAb aggregate formation
directly in cell culture samples of Chinese hamster ovary
(CHO) cells replacing falsifying, laborious and time-con-
suming chromatographic methods. Using this new
methodology, we have screened for different culture
conditions effecting mAb aggregate formation in a non-
producing and a mAb producing CHO cell line. Finally,
we have identified important process parameters to influ-
encing protein aggregation in mammalian cell culture.
Hence, our work demonstrates that the formation of
mAb aggregates can be assessed directly in mammalian
cell culture and product quality can be controlled by the
selection of certain cell culture process parameters.
Material and methods
MAb aggregation of two different CHO DG44 cell lines
was investigated using different analytical methods. LDH
level and mAb concentration were determined using a
Konelab™ 20XT analyzer (Thermo Scientific). Cell con-
centration was assessed using NyONE cell imager
(SynenTec). To distinguish between the different mAb
aggregates formed in cell culture, aggregate controls were
induced using high salt concentration (0.5 M NaCl). The
induced aggregates were used to identify extrinsic fluor-
escence dye concentration and instrument settings for
high throughput analysis of bioprocess samples. Forma-
tion of soluble mAb aggregates was assessed using the
previously described fluorescence dye-based aggregation
(FDBA) assay [5]. The formation of larger particles was
measured with 10 µM 4-4-bis-1-phenylamino-8-naphtha-
lene sulfonate (Bis-ANS) using fluorescence microscopy
on a NyONE cell imager. In order to compare the cell
culture samples, the particle count was normalized to the
lactate dehydrogenase (LDH) activity in the supernatant
of the CHO cells. We screened for cell culture para-
meters influencing mAb aggregate formation using a sta-
tistical experimental design with a linear model
(fractional factorial design, resolution IV)by varying
initial pH-value (6.8-7.6), osmolality (333-533 mOsm/kg),
agitation (100-160 rpm) and culture additives such as the
productivity enhancer valproic acid (VPA, 0-4 mM) and
antifoam (0-0.04%).
Results
Exposure to high salt concentration led to the formation of
large mAb aggregates, which were clearly distinguishable
from CHO cells due to size and morphoplogy (Figure 1,
A+B). After fluorescence labeling of the mAb aggregates
with 10 µM Bis-ANS, only mAb aggregates were visible
using green emission upon UV excitation (Figure 1, C).
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The NyONE sofware enabled further characterization
of the mAb aggregates regarding size and number
(Nuclei count, NC). Analysis of cell culture samples
over time revealed an increase of these fluorescent parti-
cles, indicating large particle formation during mAb
production in CHO cells. We used this methodology to
screen for cell culture parameters influencing mAb
aggregate formation in a non-producing (Mock) and a
producing (Producer) CHO cell line according to a
design of experiment (DoE) procedure (Table 1).
The cell growth of both cell lines was negatively
influenced by an increase of osmolality. Furthermore,
VPA negatively influenced final cell concentrations of
the mAb producing CHO cell line. Besides VPA,
osmolality enhanced specific mAb productivity. Only
agitation increased the fluorescence in the supernatant,
indicating the presence of soluble aggregates, whereas
osmolality reduced the level of large particles in both
cell lines. This negative correlation of osmolality is
surprising, since an osmolality increase e.g. by high salt
concentration can lead to mAb aggregate formation.
The slight increase of osmolality could have an impact
on the cell rather than to the product resulting in a
higher specific productivity and less formation of larger
host cell or mAb aggregate particles. VPA only
increased the particle formation of the mAb-producing
CHO cell line, indicating that VPA addition forms pro-
duct-related aggregates rather than host cell particles.
Furthermore, it was shown that VPA also altered the
N-glycosylation profile of the mAb. Finally, we could
show that the negative impact of VPA on mAb aggre-
gation was concentration-dependent and that the
VPA-induced mAb aggregates were formed intracellu-
lar and not by the presence of the fatty acid in the
supernatant [6].
Conclusions
We show that protein aggregation of mAbs can be
assessed directly in cell culture samples without falsify-
ing pre-purification procedures. Using our developed
methods we have identified critical parameters influen-
cing protein aggregation in mammalian cell culture.
Moreover, we show that mAb aggregation occurs on
two levels during USP: (1) the cellular level and (2) the
bioprocess level. Our results indicate how much protein
can be lost due to upstream protein aggregation and
help to improve production of biopharmaceuticals by
reducing the burden on expensive DSP.
Figure 1 Fluorescence microscopy images of mAb aggregates in presence of CHO cells. (A) Transmitted light images of CHO DG44 cells,
(B) NaCl-induced mAb aggregates in presence of CHO DG44 cells and (C) Bis-ANS labeled mAb aggregates in the presence of CHO DG44 cells.









Parameters Mock Producer Mock Producer Mock Producer Mock Producer
pH value 0 0 n.a. 0 0 0 0 0
Osmolality - - n.a. + 0 0 - -
Agitation 0 0 n.a. 0 + + + +
VPA 0 - n.a. + 0 0 0 +
Antifoam 0 0 n.a. 0 0 0 0 0
Result of the DoE screening: (+) Positive effect on response variable, (-) negative effect on response variable, (0) no effect on response variable, (n.a.) not
analyzed.
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